Literature DB >> 8588495

MZ female twins discordant for X-linked diseases: a review.

G Tiberio1.   

Abstract

The 20 reported cases of MZ female twins discordant for X-linked diseases are reviewed. In such twins the X-inactivation pattern is opposite skewing (abnormal allele inactivated in most cells of the normal twin, and normal allele inactivated in most cells of the affected twin) or skewing in one twin and random in the cotwin. The diseases involved map in two specific regions: Xq27-28 and Xp21. The only exceptions are Fabry's disease and Aicardi's syndrome, which map in Xq22 and Xp22 respectively. No concordant MZ female carrier twins, either normal or affected, have been described. Three main hypotheses have been proposed to explain such characteristics [2, 5, 14], but none is completely satisfactory. The constant discordance for X-linked diseases in MZ female twins has important consequences for genetic counselling.

Entities:  

Mesh:

Year:  1994        PMID: 8588495     DOI: 10.1017/s0001566000001963

Source DB:  PubMed          Journal:  Acta Genet Med Gemellol (Roma)        ISSN: 0001-5660


  9 in total

1.  Epigenetic differences arise during the lifetime of monozygotic twins.

Authors:  Mario F Fraga; Esteban Ballestar; Maria F Paz; Santiago Ropero; Fernando Setien; Maria L Ballestar; Damia Heine-Suñer; Juan C Cigudosa; Miguel Urioste; Javier Benitez; Manuel Boix-Chornet; Abel Sanchez-Aguilera; Charlotte Ling; Emma Carlsson; Pernille Poulsen; Allan Vaag; Zarko Stephan; Tim D Spector; Yue-Zhong Wu; Christoph Plass; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

Review 2.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

3.  Natural gene therapy in monozygotic twins with Fanconi anemia.

Authors:  Anuj Mankad; Toshiyasu Taniguchi; Barbara Cox; Yassmine Akkari; R Keaney Rathbun; Lora Lucas; Grover Bagby; Susan Olson; Alan D'Andrea; Markus Grompe
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

4.  Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Authors:  Allyn McConkie-Rosell; Brenda Finucane; Amy Cronister; Liane Abrams; Robin L Bennett; Barbara J Pettersen
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

5.  Genetic Counseling for Fragile X Syndrome: Recommendations of the National Society of Genetic Counselors.

Authors:  N McIntosh; L W Gane; A McConkie-Rosell; R L Bennett
Journal:  J Genet Couns       Date:  2000-08       Impact factor: 2.537

Review 6.  Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.

Authors:  Louise L C Pinto; Taiane A Vieira; Roberto Giugliani; Ida V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

Review 7.  Stochasticity or the fatal 'imperfection' of cloning.

Authors:  Reiner A Veitia
Journal:  J Biosci       Date:  2005-02       Impact factor: 2.795

Review 8.  What colour are your eyes? Teaching the genetics of eye colour & colour vision. Edridge Green Lecture RCOphth Annual Congress Glasgow May 2019.

Authors:  David A Mackey
Journal:  Eye (Lond)       Date:  2021-08-23       Impact factor: 3.775

9.  Differential phenotypic expression of a novel PDHA1 mutation in a female monozygotic twin pair.

Authors:  Alejandro Horga; Catherine E Woodward; Alberto Mills; Isabel Pareés; Iain P Hargreaves; Ruth M Brown; Enrico Bugiardini; Tony Brooks; Andreea Manole; Elena Remzova; Shamima Rahman; Mary M Reilly; Henry Houlden; Mary G Sweeney; Garry K Brown; James M Polke; Federico Gago; Matthew J Parton; Robert D S Pitceathly; Michael G Hanna
Journal:  Hum Genet       Date:  2019-10-31       Impact factor: 4.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.